Related Experiment Videos
An approach to dyspnea in cancer patients
Journal of Pain and Symptom Management
|June 1, 1989
Abstract:
There are many potential causes of dyspnea in the patient with cancer. Ultimately, a sense of increased respiratory effort is common to all of these diverse situations. An organized approach to dyspnea in the cancer patient is presented based on psychophysical principles, and treatment modalities are suggested.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies.
Journal of thrombosis and haemostasis : JTH·2016
Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study.
Journal of thrombosis and haemostasis : JTH·2015
Is it useful to also image the asymptomatic leg in patients with suspected deep vein thrombosis?
Journal of thrombosis and haemostasis : JTH·2015
Educating the Hospice Workforce on Pediatric Concurrent Care: A National Workshop Approach.
Journal of pain and symptom management·2026
End-of-Life Care Patterns by Transplant Eligibility Among Patients with End Stage Kidney Disease.
Journal of pain and symptom management·2026
Determinants of Family Caregiver Well-Being in Home-Based End-of-Life Care: A Qualitative Synthesis.
Journal of pain and symptom management·2026
Time is of the Essence: Evaluating Short-Term Prognosis Tools in Cancer and Non-Cancer Patients.
Journal of pain and symptom management·2026
Impact of Satisfactory Family Coping on the Mental Health of Parents Whose Children Died of Cancer.
Journal of pain and symptom management·2026
Positive effect of methylphenidate for cancer-related cognitive impairment: a pilot randomized trial.
Journal of pain and symptom management·2026
Post-diagnosis cannabis use and its association with health status and quality of life in cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Aloesin mitigates cisplatin-induced nephrotoxicity by suppressing NF-κB-mediated oxidative stress and modulating Bax/Bcl-2/caspase pathways.
Naunyn-Schmiedeberg's archives of pharmacology·2026